R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma

NCT02428751 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

DRUG: Pegylated liposomal doxorubicin
DRUG: Doxorubicin
DRUG: Rituximab
DRUG: Cyclophophamide
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Wenqi Jiang